Overview:
Oncology offers various diagnostic and therapeutic approaches among which radiation and radioactive compounds are known to play an important role. Radiotherapy has been used in diagnostic and therapeutic applications in cancer for a long time. In cancer treatment radiation therapy uses high radiation doses to eliminate cancer cells as well as to shrink cancerous tumors.
The global oncology radiopharmaceuticals market is expected to value US$ 3,462.8 million in 2021 and is expected to show a CAGR of 6.0% over the forecast period of 2021-2028.
To Get More Business Strategies Sample Copy of Report @ https://www.coherentmarketinsights.com/insight/request-sample/4834
Impact of COVID-19 Pandemic:
Covid-19 pandemic adversely impacted several industries. It significantly impacted economies and healthcare systems all over the world. Cancer practices across the globe faced many challenges during this period specifically for ensuring continuation of cancer treatment in the pandemic. Due to increasing burden of Covid-19 cases on hospitals, the capability of handling non-emergency medical cases including cancer was reduced during this period. Thus, with decreased number of cancer diagnostic cases, the global oncology radiopharmaceuticals market was adversely impacted by the pandemic.
Market Drivers:
The adoption of radiopharmaceuticals as novel cancer therapy is growing, which in turn is expected to propel growth of the global oncology radiopharmaceuticals market over the forecast period. Radiopharmaceuticals are used for delivering radiation therapy specifically and directly to cancer cells. The adoption of radiopharmaceuticals is increasing in the oncology sector specifically for diagnosis, imaging, follow up and staging.
Market players are focused on R&D activities to test novel radiopharmaceuticals in order for addressing the growing radiopharmaceuticals use, which is expected to boost growth of the global oncology radiopharmaceuticals market over the forecast period. For instance, the U.S. Food and Drug Administration (FDA) in 2018 granted approval to a radioactive element Lutathera ((lutetium Lu 177 dotatate) to be used in the treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors
Inquire More Or Share Questions If Any Before The Purchase On This Report @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/4834
Moreover, growing inclination to use of combination therapies is also projected to boost growth of the global oncology radiopharmaceuticals market over the forecast period. For instance, as per the article published in MEDPACE, gallium-68 and lutetium-177 can be utilized together for diagnosis and treatment of neuroendocrine tumors.
Market Restraints:
Factor such as lack of skilled workforce is likely to hinder growth of the global oncology radiopharmaceuticals market over the forecast period. For instance, as per the National Cancer Institute, the number of nuclear medicine physicians trained in medical oncology and nuclear medicine is low in the U.S.
Key Players:
Key players active in the global oncology radiopharmaceuticals market are Cardinal Health, Siemens Healthcare GmbH, Jubilant Pharma Limited, Novartis AG, Bayer AG, Curium, Zionexa, GE Healthcare, Blue Earth Diagnostics, Lantheus Medical Imaging, Inc., Acrotech Biopharma, International Isotopes, Inc., Eckert & Zieger, and Nordion.
Purchase This Premium Report @ https://www.coherentmarketinsights.com/insight/buy-now/4834
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Type
- Market Snippet, By Route of Administration
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Development
- Market Trends
- Technology Landscape
- New Device/Product Launches
- PEST Analysis
- Porter’s Five Forces Analysis
- Market Dynamics
- Global Oncology Radiopharmaceuticals Market – Impact of Coronavirus (Covid-19) Pandemic
- Government Initiative to Combat Covid-19
- Impact on Overall Healthcare Market
- Demand and Supply Analysis
- Global Oncology Radiopharmaceuticals Market, By Type, 2017-2028 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Radium-223 dichloride
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Sodium iodide I-131
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Lobenguane iodine-131
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Lutetium-177
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Yttrium-90
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Fludeoxyglucose F 18
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Gallium Citrate Ga 67
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Technetium-99m
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
- Global Oncology Radiopharmaceuticals Market, By Route of Administration, 2017 – 2028 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
- Global Oncology Radiopharmaceuticals Market, By Application, 2017 – 2028 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Diagnosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
- Global Oncology Radiopharmaceuticals Market, By End User, 2017 – 2028 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Research Institute
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
View Press Release: https://www.coherentmarketinsights.com/press-release/oncology-radiopharmaceuticals-market-4100
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Mr. Shah
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States
Email: sales@coherentmarketinsights.com
Phone: U.S.: +1-206-701-6702
U.K.: +44-020-8133-4027
JAPAN: +81-50-5539-1737
INDIA: +91-848-285-0837